316 related articles for article (PubMed ID: 21524387)
1. Identification and functions of the plasma membrane receptor for thyroid hormone analogues.
Lin HY; Cody V; Davis FB; Hercbergs AA; Luidens MK; Mousa SA; Davis PJ
Discov Med; 2011 Apr; 11(59):337-47. PubMed ID: 21524387
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of nongenomic actions of thyroid hormone.
Davis PJ; Leonard JL; Davis FB
Front Neuroendocrinol; 2008 May; 29(2):211-8. PubMed ID: 17983645
[TBL] [Abstract][Full Text] [Related]
3. Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.
Davis PJ; Davis FB; Mousa SA; Luidens MK; Lin HY
Annu Rev Pharmacol Toxicol; 2011; 51():99-115. PubMed ID: 20868274
[TBL] [Abstract][Full Text] [Related]
4. Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
Yalcin M; Bharali DJ; Lansing L; Dyskin E; Mousa SS; Hercbergs A; Davis FB; Davis PJ; Mousa SA
Anticancer Res; 2009 Oct; 29(10):3825-31. PubMed ID: 19846915
[TBL] [Abstract][Full Text] [Related]
5. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone and angiogenesis.
Luidens MK; Mousa SA; Davis FB; Lin HY; Davis PJ
Vascul Pharmacol; 2010; 52(3-4):142-5. PubMed ID: 19879961
[TBL] [Abstract][Full Text] [Related]
7. Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts.
Mousa SA; Yalcin M; Bharali DJ; Meng R; Tang HY; Lin HY; Davis FB; Davis PJ
Lung Cancer; 2012 Apr; 76(1):39-45. PubMed ID: 22024450
[TBL] [Abstract][Full Text] [Related]
8. Nongenomic regulation by thyroid hormone of plasma membrane ion and small molecule pumps.
Lin HY; Tang HY; Davis FB; Mousa SA; Incerpi S; Luidens MK; Meng R; Davis PJ
Discov Med; 2012 Sep; 14(76):199-206. PubMed ID: 23021374
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone as a regulator of tumor induced angiogenesis.
Pinto M; Soares P; Ribatti D
Cancer Lett; 2011 Feb; 301(2):119-26. PubMed ID: 21183275
[TBL] [Abstract][Full Text] [Related]
10. Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac.
Davis PJ; Glinsky GV; Lin HY; Leith JT; Hercbergs A; Tang HY; Ashur-Fabian O; Incerpi S; Mousa SA
Front Endocrinol (Lausanne); 2014; 5():240. PubMed ID: 25628605
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone is a MAPK-dependent growth factor for human myeloma cells acting via αvβ3 integrin.
Cohen K; Ellis M; Khoury S; Davis PJ; Hercbergs A; Ashur-Fabian O
Mol Cancer Res; 2011 Oct; 9(10):1385-94. PubMed ID: 21821675
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of the Receptor Site for Thyroid Hormone on Integrin αvβ3.
Lin HY; Mousa SA; Davis PJ
Methods Mol Biol; 2018; 1801():61-65. PubMed ID: 29892817
[TBL] [Abstract][Full Text] [Related]
13. Human platelet aggregation and degranulation is induced in vitro by L-thyroxine, but not by 3,5,3'-triiodo-L-thyronine or diiodothyropropionic acid (DITPA).
Mousa SS; Davis FB; Davis PJ; Mousa SA
Clin Appl Thromb Hemost; 2010 Jun; 16(3):288-93. PubMed ID: 19903697
[TBL] [Abstract][Full Text] [Related]
14. Nongenomic Actions of Thyroid Hormone: The Integrin Component.
Davis PJ; Mousa SA; Lin HY
Physiol Rev; 2021 Jan; 101(1):319-352. PubMed ID: 32584192
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone and P-glycoprotein in tumor cells.
Davis PJ; Incerpi S; Lin HY; Tang HY; Sudha T; Mousa SA
Biomed Res Int; 2015; 2015():168427. PubMed ID: 25866761
[TBL] [Abstract][Full Text] [Related]
16. Thyroid Hormone, Hormone Analogs, and Angiogenesis.
Davis PJ; Sudha T; Lin HY; Mousa SA
Compr Physiol; 2015 Dec; 6(1):353-62. PubMed ID: 26756636
[TBL] [Abstract][Full Text] [Related]
17. Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis.
Davis PJ; Lin HY; Sudha T; Yalcin M; Tang HY; Hercbergs A; Leith JT; Luidens MK; Ashur-Fabian O; Incerpi S; Mousa SA
Onco Targets Ther; 2014; 7():1619-24. PubMed ID: 25258542
[TBL] [Abstract][Full Text] [Related]
18. Small molecule hormone or hormone-like ligands of integrin αVβ3: implications for cancer cell behavior.
Davis PJ; Mousa SA; Cody V; Tang HY; Lin HY
Horm Cancer; 2013 Dec; 4(6):335-42. PubMed ID: 23943159
[TBL] [Abstract][Full Text] [Related]
19. Molecular modeling of the thyroid hormone interactions with alpha v beta 3 integrin.
Cody V; Davis PJ; Davis FB
Steroids; 2007 Feb; 72(2):165-70. PubMed ID: 17166537
[TBL] [Abstract][Full Text] [Related]
20. Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor.
Davis PJ; Davis FB; Lin HY; Mousa SA; Zhou M; Luidens MK
Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1238-46. PubMed ID: 19755667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
